Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

With the promise of percutaneous treatments for patients with diseased heart valves growing, Medtronic, Inc., announced that more presentations than ever before – at least 25 – on the company's portfolio of unique transcatheter valves will be presented at Transcatheter Cardiovascular Therapeutics 2009, the world's premier annual meeting for interventional cardiologists.

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address